POLYPEPTIDE CONSTRUCTS WITH POTENT ANTI-HIV ACTIVITY
Patent Cooperation Treaty
PCT/US2025/019228
Filed on 2025-03-10
PCT/US2025/019228
Filed on 2025-03-10
COMPOSITIONS AND METHODS FOR PHARMACOLOGIC TREATMENT OF STROKE AND MYOCARDIAL ISCHEMIA REPERFUSION INJURY
US Application 18/872,564
Filed on 2024-12-06
Filed on 2024-12-06
COMPOSITIONS AND METHODS FOR PHARMACOLOGIC TREATMENT OF STROKE AND MYOCARDIAL ISCHEMIA REPERFUSION INJURY
European Patent
23820392.1
Filed on 2024-12-04
23820392.1
Filed on 2024-12-04
COMPOSITIONS AND METHODS FOR PHARMACOLOGIC TREATMENT OF STROKE AND MYOCARDIAL ISCHEMIA REPERFUSION INJURY
Canada
3258204
Filed on 2024-12-03
3258204
Filed on 2024-12-03
The Redesign of the Terminal Inverted Repeats and Transposase Protein of the piggyBat Transposon from Myotis Lucifugus Results in Hyperactivity in Human Cells
US Application 63/632,275
Filed on 2024-04-10
Filed on 2024-04-10
POLYPEPTIDE CONSTRUCTS WITH POTENT ANTI-HIV ACTIVITY
US Application 63/563,741
Filed on 2024-03-11
Filed on 2024-03-11
Inverse Agonists And Neutral Antagonists For the TSH Receptor
Japan
2016-059757
Filed on 2016-03-24
2016-059757
Filed on 2016-03-24
Multispectral/ Hyperspectral Medical Instrument
Canada
2308375
Filed on 1998-10-30
2308375
Filed on 1998-10-30
Sodium Nitrite as a Repurposed Pharmaceutical Agent Wins LES Deals of Distinction Award
The 2009 award winner for this category is a group of licensing agreements for the development of sodium nitrite as a repurposed pharmaceutical agent potentially effective against a number of serious medical conditions. The National Institutes of Health (NIH), supported by four university collaborators, was able complete exclusive license agreements with Hope Pharmaceuticals (for infused delivery) and Aires Pharmaceuticals (for inhaled delivery) to develop new treatments for conditions not well-managed by existing therapies.
Dr. Ken Jacobson Wins E.B. Hershberg Award
The American Chemical Society (ACS) has awarded Kenneth Jacobson the E.B. Hershberg Award for Important Discoveries in Medicinally Active Substances. Jacobson is a Senior Investigator at the National Institute for Diabetes and Digestive and Kidney Diseases.
Jacobson was selected for this award for his original and high-impact research in structure-based medicinal chemistry, including the discovery of G-protein receptor modulators in clinical trials.